Dual reporter comparative indexing of rAAV pseudotyped vectors in chimpanzee airway

Molecular Therapy

Volumn 18, Issue 3, 2010, Pages 594-600

  Flotte, Terence R ^a   Fischer, Anne C ^b,c   Goetzmann, Jason ^d   Mueller, Christian ^a   Cebotaru, Liudmila ^b,c   Yan, Ziying ^e   Wang, Lilli ^f   Wilson, James M ^f   Guggino, William B ^b,c   Engelhardt, John F ^e  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF LOUISIANA AT LAFAYETTE   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIREFLY LUCIFERASE; PARVOVIRUS VECTOR; RENILLA LUCIFERIN 2 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHUS BIOPSY; CHIMPANZEE; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; REPORTER GENE; RESPIRATORY EPITHELIUM; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS CAPSID; VIRUS RECOMBINANT;

ANIMALS; BIOLOGICAL EVOLUTION; DEPENDOVIRUS; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HUMANS; IMMUNE SYSTEM; LUCIFERASES; PAN TROGLODYTES; PHYLOGENY; RESPIRATORY SYSTEM; SPECIES SPECIFICITY; T-LYMPHOCYTES; TRANSGENES;

ADENO-ASSOCIATED VIRUS; ANIMALIA; MIRIDAE; PAN; RENILLA LUCIFERASE;

EID: 77649272865     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.230     Document Type: Article

References (25)

1. Fischer, AC, Beck, SE, Smith, CI, Laube, BL, Askin, FB, Guggino, SE et al. (2003). Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques. Mol Ther 8: 918-926.
2. Engelhardt, JF, Simon, RH, Yang, Y, Zepeda, M, Weber-Pendleton, S, Doranz, B et al. (1993). Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological effcacy study. Hum Gene Ther 4: 759-769. (Pubitemid 24305770)
3. Conrad, CK, Allen, SS, Afone, SA, Reynolds, TC, Beck, SE, Fee-Maki, M et al. (1996). Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther 3: 658-668.
4. Afone, SA, Conrad, CK, Kearns, WG, Chunduru, S, Adams, R, Reynolds, TC et al. (1996). In vivo model of adeno-associated virus vector persistence and rescue. J Virol 70: 3235-3241.
5. Hernandez, YJ, Wang, J, Kearns, WG, Loiler, S, Poirier, A and Flotte, TR (1999). Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model. J Virol 73: 8549-8558.
6. Chirmule, N, Xiao, W, Truneh, A, Schnell, MA, Hughes, JV, Zoltick, P et al. (2000). Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J Virol 74: 2420-2425.
7. Bals, R, Xiao, W, Sang, N, Weiner, DJ, Meegalla, RL and Wilson, JM (1999). Transduction of well-differentiated airway epithelium by recombinant adeno-associated virus is limited by vector entry. J Virol 73: 6085-6088.
8. Gruenert, DC, Finkbeiner, WE and Widdicombe, JH (1995). Culture and transformation of human airway epithelial cells. Am J Physiol 268(3 Pt 1): L347-L360.
9. Bernacki, SH, Nelson, AL, Abdullah, L, Sheehan, JK, Harris, A, Davis, CW et al. (1999). Mucin gene expression during differentiation of human airway epithelia in vitro. Muc4 and muc5b are strongly induced. Am J Respir Cell Mol Biol 20: 595-604.
10. Liu, X, Luo, M, Trygg, C, Yan, Z, Lei-Butters, DC, Smith, CI et al. (2007). Biological Differences in rAAV Transduction of Airway Epithelia in Humans and in Old World Non-human Primates. Mol Ther 15: 2114-2123.
11. Yan, Z, Lei-Butters, DC, Liu, X, Zhang, Y, Zhang, L, Luo, M et al. (2006). Unique biologic properties of recombinant AAV1 transduction in polarized human airway epithelia. J Biol Chem 281: 29684-29692.
12. Seiler, MP, Miller, AD, Zabner, J and Halbert, CL (2006). Adeno-associated virus types 5 and 6 use distinct receptors for cell entry. Hum Gene Ther 17: 10-19.
13. Liu, X, Yan, Z, Luo, M and Engelhardt, JF (2006). Species-specifc differences in mouse and human airway epithelial biology of recombinant adeno-associated virus transduction. Am J Respir Cell Mol Biol 34: 56-64.
14. Moss, RB, Rodman, D, Spencer, LT, Aitken, ML, Zeitlin, PL, Waltz, D et al. (2004). Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fbrosis transmembrane regulator gene transfer to the lungs of patients with cystic fbrosis: a multicenter, double-blind, placebo-controlled trial. Chest 125: 509-521.
15. Gao, G, Vandenberghe, LH and Wilson, JM (2005). New recombinant serotypes of AAV vectors. Curr Gene Ther 5: 285-297.
16. Crowe, JE Jr, Collins, PL, London, WT, Chanock, RM and Murphy, BR (1993). A comparison in chimpanzees of the immunogenicity and effcacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV. Vaccine 11: 1395-1404.
17. Bukh, J (2004). A critical role for the chimpanzee model in the study of hepatitis C. Hepatology 39: 1469-1475.
18. Wu, Z, Miller, E, Agbandje-McKenna, M and Samulski, RJ (2006). Alpha2,3 and alpha2,6 N-linked sialic acids facilitate effcient binding and transduction by adeno-associated virus types 1 and 6. J Virol 80: 9093-9103.
19. Vandenberghe, LH, Wang, L, Somanathan, S, Zhi, Y, Figueredo, J, Calcedo, R et al. (2006). Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid. Nat Med 12: 967-971.
20. Chen, S, Kapturczak, M, Loiler, SA, Zolotukhin, S, Glushakova, OY, Madsen, KM et al. (2005). Effcient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors. Hum Gene Ther 16: 235-247.
21. Zabner, J, Seiler, M, Walters, R, Kotin, RM, Fulgeras, W, Davidson, BL et al. (2000). Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J Virol 74: 3852-3858.
22. Zolotukhin, S, Potter, M, Zolotukhin, I, Sakai, Y, Loiler, S, Fraites, TJ Jr et al. (2002). Production and purifcation of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28: 158-167. (Pubitemid 35341079)
23. Hauswirth, WW, Aleman, TS, Kaushal, S, Cideciyan, AV, Schwartz, SB, Wang, L et al. (2008). Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther 19: 979-990.
24. Lin, J, Calcedo, R, Vandenberghe, LH, Figueredo, JM and Wilson, JM (2008). Impact of preexisting vector immunity on the effcacy of adeno-associated virus-based HIV-1 Gag vaccines. Hum Gene Ther 19: 663-669.
25. Fu, TM, Dubey, SA, Mehrotra, DV, Freed, DC, Trigona, WL, Adams-Muhler, L et al. (2007). Evaluation of cellular immune responses in subjects chronically infected with HIV type 1. AIDS Res Hum Retroviruses 23: 67-76.